Advertisement

Topics

FDA Approves KALYDECO® (ivacaftor) for More Than 600 People Ages 2 and Older With Cystic ...

03:06 EDT 1 Aug 2017 | BioMedReports - Blog
Vertex Pharmaceuticals Incorporated
Investors:
Michael Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach Barber, 617-341-6470
or
Media:
mediainfo@vrtx.com
or
North America:
Heather Nichols, +1 617-961-0534
or
Europe & Australia:
Megan Goulart, +44 20 3204 5275

Read more...

Original Article: FDA Approves KALYDECO® (ivacaftor) for More Than 600 People Ages 2 and Older With Cystic ...

NEXT ARTICLE

More From BioPortfolio on "FDA Approves KALYDECO® (ivacaftor) for More Than 600 People Ages 2 and Older With Cystic ..."

Quick Search
Advertisement